TickerFactsScreenerDevelopers

Skye Bioscience, Inc. (SKYE) — Total Assets

Annual figures by fiscal year, from SEC filings.

2012: $42.9K2013: $145.7K2014: $348.3K2015: $3.51M2016: $323.4K2017: $557.2K2018: $1.96M2019: $2.00M2020: $2.67M2021: $9.86M2022: $9.11M2023: $11.94M2024: $72.76M2025: $28.31M$28.31M
2012Total Assets (USD)2025
Fiscal YearTotal AssetsChange YoY
2025$28.31M-61.1%
2024$72.76M+509.4%
2023$11.94M+31.1%
2022$9.11M-7.5%
2021$9.86M+268.9%
2020$2.67M+33.8%
2019$2.00M+2.0%
2018$1.96M+251.2%
2017$557.2K+72.3%
2016$323.4K-90.8%
2015$3.51M+907.9%
2014$348.3K+139.1%
2013$145.7K+239.7%
2012$42.9K—